Skip to main content
. 2022 Jan 21;23(3):1200. doi: 10.3390/ijms23031200

Table 2.

Evaluation of in vitro metabolic activity of human cells derived from colorectal carcinoma (CaCo-2) and human primary fibroblasts (MRC-5) treated with PLGA_OXA and PLGA_IO_OXA for 72 h determined by WST-1 assay. IC50—concentration of the nanoparticles required to achieve 50 % reduction in cell viability; SD—standard deviation (from four replicates).

IC50 ± SD [µg·mL−1] of the Nanoparticles
Cell line PLGA_OXA PLGA_IO_OXA
CaCo-2 255 ± 11 560 ± 62
MRC-5 525 ± 12 325 ± 31